Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2014

View Archived Issues

Bayer presents first-in-human and promising in vivo data for BAY-85-8501

Discovery of novel allosteric GSK-3 inhibitors for the treatment of neurodegenerative diseases

Sanofi and MyoKardia form collaboration to develop treatments for genetic cardiomyopathies

Genzyme product receives orphan designation for Gaucher's disease

Legalon Sil given FDA orphan designation for amatoxin poisoning

BA-321, a selective androgen receptor modulator for treatment of male osteoporosis

Cell Cure Neurosciences shows safety and efficacy of OpRegen in animal studies

Metabolon partners with Metdia for European commercialization of prediabetes tests

Sutro Biopharma and Merck KGaA establish ADC collaboration agreement

Glenmark completes phase IIa study of TRPA1 receptor antagonist

USP7 gene polymorphisms linked to breast cancer susceptibility in Chinese women

World Alzheimer's Day: Research efforts towards early diagnosis and new therapeutic strategies

Research looks into role of betatrophin in human diabetes and its potential as a biomarker

Shionogi discloses novel AMPK activators for diabetes

Avraham Pharmaceuticals raises additional funding to advance ladostigil development

Mochida Pharmaceutical synthesizes new PDE10 inhibitors

Janssen patents novel compounds for HBV infection

Scientists at Bristol-Myers Squibb disclose new agents for cancer

Therabiol divulges new vaccines for HIV infection

Pocket consortium updates on tuberculosis diagnostic device

Zydelig approved in E.U. for chronic lymphocytic leukemia and follicular lymphoma

Fred Hutchinson Cancer Research Center receives grant to run infection epidemiology center

Umecrine Mood reports results from phase I/II trial of UC-1010

Japanese approval of Eylea for myopic choroidal neovascularization

Nuvilex advances Cell-in-a-Box programs for pancreatic cancer and diabetes

Qu Biologics closes private financing

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026